Eli Lilly will acquire Centessa Pharmaceuticals for $6.3 billion; CNTA shares jumped 44.4% to $39.90 on the announcement. The deal is a significant M&A outcome for the biotech sector and materially benefits Centessa shareholders while boosting sector sentiment.
Eli Lilly will acquire Centessa Pharmaceuticals for $6.3 billion; CNTA shares jumped 44.4% to $39.90 on the announcement. The deal is a significant M&A outcome for the biotech sector and materially benefits Centessa shareholders while boosting sector sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
